$21.11
0.000.00%
Pre-Market: 4:00 PM EDT
Comments
Loading...
Guardian Pharmacy Service Stock Guidance | NYSE:GRDN | Benzinga
Guardian Pharmacy Service issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 03/26/2025 | GRDN | Guardian Pharmacy Service | FY | 2025 | — | — | — | $1.33B | $1.35B | $1.34B | Get Alert |
| 03/03/2025 | GRDN | Guardian Pharmacy Service | Q4 | 2024 | — | — | — | $338.60M | $338.60M | $320.52M | Get Alert |
| 03/03/2025 | GRDN | Guardian Pharmacy Service | FY | 2024 | — | — | — | $1.23B | $1.23B | $1.21B | Get Alert |
| 03/03/2025 | GRDN | Guardian Pharmacy Service | FY | 2025 | — | — | — | $1.33B | $1.35B | $1.33B | Get Alert |
| 11/12/2024 | GRDN | Guardian Pharmacy Service | FY | 2024 | — | — | — | $1.21B | $1.22B | $1.19B | Get Alert |
FAQ
What is the most recent guidance for Guardian Pharmacy Service (GRDN)?
There have been no specific sales or earnings guidance reported for Guardian Pharmacy Service in recent months.
Browse guidance and forecast on all stocks.